MLi-2
MLi-2, a chemical probe, is an orally active and highly selective LRRK2 inhibitor with an IC50 of 0.76 nM. MLi-2 has the potential for Parkinson’s disease[1].
Product Specifications
CAS Number
[1627091-47-7]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
LRRK2
Type
Reference compound
Related Pathways
Autophagy
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/MLi-2.html
Purity
99.80
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
C[C@@](C1)([H])O[C@](C)([H])CN1C2=CC(C3=NNC4=CC=C(OC5(C)CC5)C=C43)=NC=N2
Molecular Formula
C21H25N5O2
Molecular Weight
379.46
Precautions
H302, H315, H319, H335
References & Citations
[1]Fell MJ, et al. MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition. J Pharmacol Exp Ther. 2015 Dec;355 (3) :397-409.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
249341-ML750 100 µL
NLGN1 (Neuroligin 1, KIAA1070, MGC45115) (MaxLight 750) discontinued
Ask
View Details 
GTR15283685 1 Vial
Lentiviral mouse Usp48 shRNA (UAS) - Lentiviral mouse Usp48 shRNA (UAS) (25)
Ask
View Details MBS1376412-01 0.02 mg (E-Coli)
Recombinant Borrelia afzelii Serine--tRNA ligase (serS)
Ask
View Details 
MBS1376412-02 0.02 mg (Yeast)
Recombinant Borrelia afzelii Serine--tRNA ligase (serS)
Ask
View Details